Skip to main content
Clinical Trials/CTRI/2024/07/070053
CTRI/2024/07/070053Not yet recruitingPhase 3 4

Analytical study of centesimal scale potencies in managing acute febrile illness in paediatric cases

Post Graduate Research funded by College1 site in 1 country30 target enrollmentStarted: July 16, 2024Last updated:
Conditions
Drugs

Trial Snapshot

Phase
Phase 3 4
Status
Not yet recruiting
Sponsor
Enrollment
30
Locations
1
Primary Endpoint
A decrease in severity of symptoms and temperature will serve as a means for assessing progress

Study Overview

Brief Summary

Fever is defined as the elevation of core temperature above normal (36.60C to 370C), which is a   component of the defensive responses of multicellular organisms (host) to the invasion of live (microorganisms) or inanimate matter recognized as pathogenic or alien by the host. This definition highlights the adaptive nature of the febrile response. This study is to find the effectiveness of various potencies in centesimal scale in treating fever.

Study Design

Study Type
Interventional
Allocation
Na
Masking
None

Eligibility Criteria

Ages
1.00 Year(s) to 18.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • Age groups.
  • 1 to 18 years Both male and female Temperature range : 99 to 103F.

Exclusion Criteria

  • Complicated fevers Fever with temperature more than 103 F Hyperpyrexia.

Outcomes

Primary Outcomes

A decrease in severity of symptoms and temperature will serve as a means for assessing progress

Time Frame: 7 days

Secondary Outcomes

  • Most effective drugs in treating fevers in homoeopathy(1 year)

Investigators

Sponsor
Post Graduate Research funded by College
Sponsor Class
Private medical college
Responsible Party
Principal Investigator
Principal Investigator

Dr Robin K James

Sarada Krishna Homoeopathic Medical College

Study Sites (1)

Loading locations...

Similar Trials